TCON Tracon Pharmaceuticals Inc

TRACON Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases.

As of 09/16/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/30/2015
Outstanding shares:  19,430,369
Average volume:  149,140
Market cap:   $73,641,099
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    89237H209
ISIN:        US89237H2094
Sedol:      BG0WPF7
Valuation   (See tab for details)
PE ratio:   -8.28
PB ratio:   4.95
PS ratio:   212.84
Return on equity:   -151.17%
Net income %:   -5,205.72%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy